Oncology & Cancer

Less frequent biopsy may be option in prostate cancer care

(HealthDay)—Biennial biopsies are an acceptable alternative to annual biopsies for men managing low-risk prostate cancer through active surveillance (AS), according to a research published online Nov. 27 in the Annals of ...

Oncology & Cancer

Biomarker could lead to personalized therapies for prostate cancer

In 2016, more than 181,000 new cases of prostate cancer were reported in the U.S., according to the American Cancer Society. The prostate-specific antigen (PSA) test is one of the earliest ways clinicians can detect prostate ...

Oncology & Cancer

Targeting of tracked tumor foci ups gleason score upgrading

(HealthDay)—Targeting of tracked tumor foci allows for improved detection of Gleason score 4 + 3 or greater cancers among men under active surveillance for prostate cancer, according to a study published in the March issue ...

page 1 from 3